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Abstract 
Objectives: The objective of this study is to evaluate the efficacy of self and professionally applied desensitizing 
agents in relieving dentinal hypersensitivity after single direct topical application. 
Study Design: This was a randomized controlled trial conducted among 57 patients. 8% Arginine paste was self-
applied by the subject and Gluma desensitizer was applied by investigator. Numeric rating scale was used to mea-
sure hypersensitivity after tactile stimulus, Schiff scale was used for cold and air blast stimuli respectively. Scores 
were recorded at baseline, immediately, 15 and 30 days after the application.  Friedman, Wilcoxon test as post hoc 
was used to analyze within group differences, between group differences analyzed using Mann Whitney U test 
(P<0.05 considered significant). 
Results: 8% Arginine paste elicited significantly higher reductions in sensitivity (P<0.05) than that of Gluma group 
at all follow ups. There was a significant decrease in hypersensitivity for both the groups from baseline till final 
follow-up (P<0.05) for all three stimuli. 8% Arginine paste was found to be more effective than Gluma desensitizer 
in providing immediate relief from dentine hypersensitivity and also sustained the effect significantly for a period 
of 30 days.
Conclusions: Self applied 8% Arginine paste is effective than professionally applied Gluma desensitizer in relie-
ving dentinal hypersensitivity immediately and over a period of one month.
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Introduction
Dentinal hypersensitivity [DH] is a common condition 
in daily practice, especially in patients who have abra-
sion, attrition, gingival recession and erosion of teeth. It 
usually affects individuals in their thirties, although it 
can affect individuals in the age range of 20-50 years (1). 
The buccal-cervical regions of the canine and premolar 
teeth, also sites which are most susceptible to gingival 
recession are the ones most commonly affected by denti-
nal hypersensitivity (2). The discomfort experienced by 
individuals suffering from DH is short and sharp pain 
caused by exposed dentinal tubules in response to stimu-
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Material and Methods 
This study was a randomized, double blind, single site 
controlled clinical trial conducted in the Comprehensive 
Dental Care Center, Udupi; Karnataka from July 2012 
till March 2013. Institutional review board of Kastur-
ba Hospital Ethics Committee reviewed, approved the 
study protocol [IEC 161/ 2012]. Individual tooth was 
the unit of the study in this trial. 57 patients [114 tee-
th] including 32 men and 25 women between the age 
group of 20 and 50 years [Mean age 33.9 ± 7.8] were 
recruited. Principal investigator clinically evaluated all 
participants to confirm that they had DH and included 
eligible subjects in the trial based on the following in-
clusion and exclusion criteria. Inclusion criteria were as 
follows: subjects between the age group of 20-50 years, 
presenting with complaint of hypersensitivity, those with 
cervical erosion/abrasion or gingival recession and those 
having a minimum of two teeth with dentinal hypersen-
sitivity. Subjects were excluded from the study if they 
had any history of allergies or idiosyncrasies to denti-
frice ingredients, gross oral pathology, chronic diseases, 
advanced periodontal disease, treatment for periodontal 
disease [within previous 12 months], hypersensitive tee-
th with mobility greater than one [Miller, 1938] and tho-
se with teeth that have extensive/defective restorations 
[including prosthetic crowns], suspected pulpitis, caries, 
cracked enamel, or those teeth being used as abutments 
for removable partial dentures and who are current users 
of anticonvulsants, antihistamines, antidepressants, se-
datives, tranquilizers, anti-inflammatory drugs, or daily 
analgesics. Informed consent was obtained before the 
commencement of the trial. Subjects not willing to pro-
vide consent were not included in the trial.
The sample size was determined based on the pilot stu-
dy conducted among 10 participants [20 teeth]. 10 teeth 
each were randomly allotted to both Gluma and Argini-
ne group. The pooled variance was calculated based on 
the results obtained. A difference of 1 in the Schiff sco-
res between the baseline and the follow up after 30 days 
in the Schiff sensitivity scale (9) was considered to be 
indicative of clinically accepted success. Final estimated 
sample was 46 per group.
Randomization: A total of 114 teeth were included in 
the trial and were randomly allocated to the two groups; 
(54) Gluma and (60) Arginine respectively using fish 
bowl randomization. Recording of DH at baseline, im-
mediately, 15 days and after 30 days were recorded by 
second investigator who was blinded as to which group 
the particular tooth belonged. Each tooth was evaluated 
for tactile, air blast and cold stimuli on causing dentinal 
hypersensitivity. A trained recorder helped the investi-
gator in recording the DH scores at each follow up. All 
the subjects were instructed to use non fluoridated too-
thpaste, as it can confound the results. This was ensured 
by prescribing non-fluoridated toothpaste [Miswak] to 
li like thermal, tactile, osmotic, chemical or evaporative; 
that cannot be ascribed to any disease. Several theories 
like transduction, neural stimulation and hydrodynamic 
theories have been proposed for the causal of DH, but 
the most widely accepted is the hydrodynamic theory 
(3). Customarily, the first treatment option for DH would 
be recommending desensitizing toothpaste. When used 
regularly over a few weeks many individuals feel re-
lieved, although it is not a permanent solution. If the 
self-use prescriptions fail to work, professional methods 
of sealing the dentinal tubules would be considered. 
Self-applied desensitizing agents have the advantage 
of immediate availability for treatment as compared to 
those which are applied by a professional. Nevertheless, 
professionally applied desensitizing agents theoretically 
have the advantage of immediate relief from the symp-
toms. The disadvantage with the self-applied agents is 
the time required for the relief of symptoms associated 
with DH. It usually takes about 2-4 weeks for remission 
of symptoms (4). Professionally sealing the exposed 
dentinal tubules is restricted to in-office products like, 
HEMA-G [Hydroxyethyl Methacrylate and Glutaralde-
hyde], fluoride varnish, fluoride iontophoresis and lasers. 
These materials have been proved to provide relief from 
DH in one or more professional applications. HEMA-G 
prevents DH by coagulating the proteins and amino 
acids within the dentinal tubules (5). Nevertheless, the 
number of people seeking professional help is low be-
cause of the ever increasing cost of visiting a dentist for 
treatment. Two major approaches are presently available 
in treating DH. First is to interrupt the neural response 
to triggering factors; secondly, by occluding the exposed 
dentinal tubules thereby blocking the hydrodynamic me-
chanism (6). Markowitz and Pashley suggested that the 
treatment should focus on increasing the surface mineral 
density of exposed dentin, use of calcium rich material 
for sealing exposed dentin, accelerate natural desensiti-
zing process of occluding open tubules (7). The recently 
introduced Pro-arginine technology for the treatment of 
DH has been found to be effective in reducing the DH, 
either self-applied or professionally applied. The mecha-
nism of action of Pro-arginine is that it mimics natural 
desensitizing process leading to spontaneous occlusion 
of open dentinal tubules by the formation of calcium and 
phosphate plugs (8). This paste has been introduced in 
a concentration of 8.0% for relieving DH by both self 
and professional application. Thus the purpose of this 
double blind, randomized clinical trial was to evaluate 
the clinical efficacy of self-applied Colgate sensitive 
Pro-Relief  [Colgate-Palmolive, Guildford, Surrey, UK], 
and professionally applied Gluma Desensitizer [Heraeus 
Kulzer, Armonk, NY, USA] in relieving the dentinal 
hypersensitivity after a single direct topical application 
over a period of one month.
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be purchased from the pharmacy. Subjects were also ins-
tructed not to use any mouthwash during the course of 
the study.
Assessment of tactile, air blast and cold hypersensitivi-
ty: Tactile stimuli were evaluated by running an explorer 
[17/23] perpendicular to buccal-cervical/ exposed root 
surface. The score was recorded on a numerical rating 
scale ranging from 1-10 [0 no pain, 1-3 mild, 4-6 mo-
derate, 7-10 severe]. Air was delivered from a standard 
dental unit air syringe at 40 psi [± 5 psi] and 70°F [± 
3°F] directed at the exposed buccal surface of the hy-
persensitive tooth for two seconds from a distance of 
approximately 10 mm to elicit air blast hypersensitivi-
ty. Cold sensitivity was assessed by injecting 0.2 ml of 
ice cold water from a pre cooled syringe onto the tooth 
which is isolated using cotton rolls. The Schiff Cold Air 
Sensitivity Scale (9) was used to assess subject response 
to air blast and cold stimulus.  Evaluation for various sti-
muli was performed with a time interval of five minutes 
between each. Subjects who gave a minimum score of  3 
for numeric rating scale [tactile] and a minimum of 2 in 
Schiff’s sensitivity scale [air blast/ cold stimuli] during 
the baseline examination were recruited in the study. The 
tooth to be treated were isolated from the adjacent teeth 
using cotton rolls and 8% Arginine paste was applied by 
taking small increment of the paste in a finger and mas-
saged over the buccal-cervical area of the tooth by the 
patient for a minute after which the patient is asked to 
rinse gently with water. Gluma desensitizer was applied 
using an applicator tip onto the tooth being treated by the 
investigator and allowed to dry for a minute after which 
the patient was asked to rinse gently with water. Subjects 
were recalled and dentinal hypersensitivity was evalua-
ted for tactile, air blast and cold stimuli immediately, 15, 
30 days after the application of desensitizing agents. All 
the patients were communicated on their cell phone on 
day before the follow up to remind them, further a short 
message service [SMS] was sent on the morning of the 
follow up to avoid loss as much as possible. This method 
was very effective in motivating the patients. 
Statistical methods: Normality of the data was analy-
zed for each group using Shapiro Wilk test [p<0.001]. 
Data was found to be non-normally distributed, hence 
non parametric test were employed using SPSS 16.0 
for windows [SPSS Inc, Chicago, IL, USA] to analyze 
them. The within group differences at different time fra-
mes were compared using Friedman test and Wilcoxon 
signed rank test with bonferroni correction used as post 
hoc. Comparison of the between groups based on base-
line assessments and subsequent follow ups were per-
formed using Mann-Whitney U test to assess the chan-
ge in mean score from baseline. All the statistical tests 
were two sided and P value was adjusted [Bonferroni 
method]; α = 0.05 was used as an overall experiment 
error rate.
Results
57 subjects with a mean age of 33.9 ±7.8 years were re-
cruited in the study and five [9%] were lost to follow up 
[three subjects from Gluma group, two from Arginine], 
thus were excluded from the final analysis. Finally, 52 
subjects [104 teeth] completed the 30 days clinical trial. 
Distribution of study population according to age and 
gender of subjects in all the three groups is presented in 
Table 1. Friedman test showed a statistically significant 
reduction [P<0.05] in mean score for DH from baseline 
to all subsequent follow ups within both treatment group. 
Wilcoxon test with bonferroni correction used as a post 
hoc analysis showed a significant reduction [P<0.0167] 
in the mean score for DH from baseline-immediately, 
baseline-15 days and baseline-30 days for both Argini-
ne and Gluma groups (Table 2). Between groups com-
parison for Gluma and Arginine is presented in Table 
3. Mann-Whitney U test found significant reductions 
[P<0.05] in the mean DH among the two groups. When 
the DH was elicited by all three stimuli, Arginine group 
significantly reduced [P<0.05] DH during all the follow 
ups as compared to that of Gluma group, except for air 
blast sensitivity at 15 days follow up.
Table 1. Summary of age and gender of all the subjects who completed 
the trial.
Treatment 
group
Number of subjects Age 
Male Female Total Mean Range 
Gluma 14 10 24 32.8 22-46
Arginine 11 17 28 32.2 21-49
Discussion
In this study the efficacy of two desensitizing agents 
were compared in a single site, controlled, double blind, 
and parallel design trial to reduce DH after single di-
rect self and professionally applied agents. The two des-
ensitizing agents used are completely different in their 
chemical composition and mode of action. The profes-
sionally applied agent, Gluma desensitizer a proven des-
ensitizing agent, acts by coagulating the proteins within 
the dentinal tubule (5,10). The self-applied agent, Col-
gate sensitive pro relief contains a novel desensitizing 
agent, 8% arginine, bicarbonate and calcium carbonate, 
thereby, forming dentin plugs to prevent DH. 
The results of the present study demonstrate compara-
ble clinical effectiveness among both the desensitizing 
agents with significant reductions in the measure of den-
tine hypersensitivity till the 30th day after single direct 
topical application. Prominent and clinically relevant 
reductions [p<0.05] in the pain caused by tactile, air-
blast and cold stimuli were found in both the groups. 
However, when compared between the groups, Argini-
ne containing paste was found to be more effective in 
reducing DH. Arginine paste was also found to sustain 
the immediate desensitization achieved to period of 30 
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days as compared to Gluma. This result is in accordan-
ce with results from studies, which the desensitization 
achieved through the use of Pro-arginine technology is 
immediate and lasts up to 28 days (11,12). The possible 
explanation for the result observed in the present study 
may relate to the effectiveness of arginine in sealing the 
dentinal tubules, its acid resistant nature and the depth 
of the plug [2µm] formed within the tubule as found in 
various confocal and scanning electron microscopic stu-
dies (13).  Result of similar research evaluating the effi-
cacy of Arginine in providing instant relief after single 
direct topical self-application is in concordance with the 
results obtained in this study (14,15). In a study by Olu-
sile, Gluma was found to be most effective in the first 
24 hour period (16). Ozen T and others evaluated the 
efficacy of Gluma, Ultra EZ and Duraphat in reducing 
dentinal hypersensitivity in short term treatment period 
against a placebo. They found that Gluma performed 
best, but without any significant difference with others 
(17). Although, Gluma is considered to be an effective 
in-office desensitizing agent, it was not found to be as 
effective as Colgate sensitive pro relief in our study. One 
of the reasons probably could be the lack of acid resis-
tance of Gluma which can explain the lack of longevity 
observed. The cervical areas of the tooth are the ones 
most susceptible to DH, but are also known for plaque 
stagnation; hence, Gluma could have been lost because 
of the acids produced from the plaque accumulated.
DH is a common disease, whose prevalence and symp-
toms has been studied in a variety of population across 
the globe. There are no established parameters to mea-
sure DH, and reporting of DH is also not homogeneous 
among investigators. Millions of people are affected by 
DH and for some it also affects the QoL and daily activi-
ties (18). The prevalence of DH is expected to increase, 
so is the demand for effective management of DH. Me-
dicine and dentistry has evolved into a new era of pro-
longing life expectancy and preserving life. The longer 
the person lives and retains teeth in older age, more is 
the chance for DH.  Reasons for the increase in preva-
Stimuli Time point Mean (SD) 
Glumac=50
Mean (SD) 
Arginined=54
P valuea P valueb 
Tactile Baseline 5.20 (1.6) 5.70 (1.7)
< 
0.001c,d*
Baseline-immediatelyc,d < 0.001†
Immediately 1.6 (1.5) 0.76(1.2) Baseline-Days 15c,d < 0.001†
Days 15 1.2 (1.2) 0.37(1.1) Baseline-Days 30c,d < 0.001†
Days 30 1.8 (1.6) 0.22(.79)
Air blast Baseline 2.5 (0.5) 2.7 (0.5)
< 
0.001c,d*
Baseline-immediatelyc,d < 0.001†
Immediately 0.7 (0.7) 0.41 (0.6) Baseline-Days 15c,d < 0.001†
Days 15 0.4 (0.7) 0.18 (0.4) Baseline-Days 30c,d < 0.001†
Days 30 0.9 (0.9) 0.14 (0.4)
Cold Baseline 2.7 (0.4) 2.8 (0.4)
< 
0.001c,d*
Baseline-immediatelyc,d < 0.001†
Immediately 0.8 (0.7) 0.57 (0.7) Baseline-Days 15 < 0.001†
Days 15 0.7 (0.9) 0.25 (0.5) Baseline-Days 30c,d < 0.001†
Days 30 1.2 (0.9) 0.11 (0.4)
A - Results of Friedman test; *P <0.05 considered significant,
B - Results of Wilcoxon test;  †P <0.0167 considered significant,
C - Within group analysis for Gluma group,
D - Within group analysis for Arginine group
Table 2. Within group comparisons of dentinal hypersensitivity scores (Mean ± SD) to various stimuli at three 
different intervals in Gluma and Arginine group.
Table 3. Comparison of dentinal hypersensitivity scores (Mean ± SD) for tactile, airblast and cold stimuli at three 
different intervals among Gluma and Arginine groups.
Evaluations N Tactile 
stimuli
P 
valuea
Air blast
stimuli 
P 
valuea
Cold 
stimuli
P 
valuea
Mean
(SD)
Mean
(SD)
Mean
(SD)
Baseline Gluma 50 5.2 (1.6) 0.114 2.5 (0.5) 0.134 2.7 (0.4) 0.295
Arginine 54 5.7 (1.7) 2.7 (0.5) 2.9 (0.4)
Immediately Gluma 50 1.6 (1.5) 0.006* 0.7 (0.7) 0.02*  0.9 (0.7)  0.017*
Arginine 54 0.8 (1.2) 0.4 (0.6) 0.6 (0.8)
Day 15 Gluma 50 1.1 (1.2) < 0.001* 0.4 (0.7) 0.06 0.7 (0.9) 0.018*
Arginine 54 0.3 (1.0) 0.9 (0.4) 0.3 (0.5)
Day 30 Gluma 50 1.8 (1.6) < 0.001*  0.9(1.0) < 0.001* 1.2 (0.9) < 0.001*
Arginine 54 0.2 (0.7) 0.1 (0.4) 0.1 (0.4)
A - Results of Mann-Whitney U test , *P <0.05 considered significant
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lence may also be attributed to the lifestyle alterations, 
habits and behavioral changes. It is quite striking that 
despite the extended prevalence, not many opt for clini-
cal management or use of desensitizing agents (19). The 
rationale behind the reduced use of desensitizing agents 
may be because of the high cost involved in visiting a 
dentist, costlier desensitizing agents and also because of 
objectionable taste and stinging effect on oral mucosa, 
which discourages tolerability and continuous use.
To the best of our knowledge this is the first study to 
evaluate the efficacy of self-application and professio-
nal application in reducing DH after single direct topical 
application using arginine containing tooth paste and 
Gluma desensitizer. Negative control could not be used 
in our study, because it was not ethically and morally 
right to deny treatment as DH affects the daily activities, 
but it’s the major limitation of this study. Lack of control 
does affect the interpretation of the results of this stu-
dy with respect to the response measured. Thus, authors 
recommend clinical trials testing the efficacy of desen-
sitizing agents to have negative control arm to further 
strengthen the study findings. The main challenge for 
epidemiological comparisons is the definition and the 
clinical methodology employed, each study varies from 
investigator to investigator, no gold standard exists as to 
carry out desensitizing studies.
Conclusions
In conclusion, this study demonstrates the efficacy of 
self-applied Arginine containing toothpaste [Colgate 
sensitive pro relief] in reducing the DH and sustaining 
it reasonably for a period of 30 days when compared 
to professionally applied Gluma desensitizer after a 
single topical application. It can serve as an effective 
agent in treating DH rather than vising the dentist for the 
treatment of the same, thereby, also reducing the costs 
involved in visiting a dentist.
References
1. Gillam DG, Aris A, Bulman JS, Newman HN, Ley F.  Dentine hy-
persensitivity in subjects recruited for clinical trials:clinical evaluation, 
prevalence and intra-oral distribution. J Oral Rehabil. 2002;29:226-
31.
2. Addy M. Dentine hypersensitivity:new perspectives on an old pro-
blem. Int Dent J. 2002;52:375-86.
3. Brannstrom M, Astrom A. The hydrodynamics of the dentine;its 
possible relationship to dentinal pain. Int Dent J. 1972;22:219-27.
4. Porto IC, Andrade AK, Montes MA. Diagnosis and treatment of 
dentinal hypersensitivity. J Oral Sci. 2009;51:323-32.
5. Schüpbach P, Lutz F, Finger WJ. Closing of dentinal tubules by 
gluma desensitizer. Eur j Oral Sci. 1997;105:414-21.
6. Ling TY, Gillam DG. The effectiveness of desensitizing agents for 
the treatment of cervical dentine sensitivity (CDS) – A review. J West 
Soc Periodontal Periodontal Abstr. 1996;44:5-12.
7. Markowitz K, Pashley DH. Discovering new treatments for sen-
sitive teeth:the long path from biology to therapy. J Oral Rehabil. 
2008;35:300-15.
8. Kleinberg I. Sensistat. A new saliva-based composition for sim-
ple and effective treatment of dentinal sensitivity pain. Dent today. 
2002;21:42-7.
9. Schiff T, Dotson M, Cohen S, Devizio W, Mccool J, Volpe A. 
Efficacy of a dentifrice containing potassium nitrate, soluble pyro-
phosphate, PVM/MA copolymer, and sodium fluoride on dentinal 
hypersensitivity:a twelve week clinical study. J Clin Dent. 1994;5:87-
92.
10. Gugnani S, Gupta R, Pandit N. Comparative evaluation of two 
commercially available desensitizing agents after scaling and root 
planning:an in vivo study. Perio. 2008;5:121-9.
11. Wolff MS, Kaufman H, Kleinberg I. Dentinal hypersensitivity 
following scaling and root planning (SRP) and dental prophylaxis. J 
Dent Res. 2002;80:191.
12. Schiff T, Delgado E, Zhang YP, Cummins D, Devizio W, Mateo 
LR. Clinical evaluation of the efficacy of an in-office desensitizing 
paste containing 8.0% arginine and calcium carbonate in provi-
ding instant and lasting relief of dentin hypersensitivity. Am J Dent. 
2009;22:8a-15a.
13. Petrou I, Heu R, Stranick M, Lavender S, Zaidel L, Cummins D, 
Sullivan RJ, Hsueh C, Gimzewski JK. A breakthrough therapy for den-
tin hypersensitivity:how dental products containing 8% arginine and 
calcium carbonate work to deliver effective relief of sensitive teeth. J 
Clin Dent. 2009;20:23-31.
14. Schiff T, Delgado E, Zhang YP, Devizio W, Cummins D, Mateo 
LR. The clinical effect of a single direct topical application of a den-
tifrice containing 8.0% arginine, calcium carbonate, and 1450 ppm 
fluoride on dentin hypersensitivity:the use of a cotton swab applicator 
versus the use of a fingertip. J Clin Dent. 2009;20:131-6.
15. Nathoo S, Delgado E, Zhang YP, Devizio W, Cummins D, Mateo 
LR. Comparing the efficacy in providing instant relief of dentin hyper-
sensitivity of a new toothpaste containing 8.0% arginine, calcium car-
bonate, and 1450 ppm fluoride relative to a benchmark desensitizing 
toothpaste containing 2% potassium ion and 1450 ppm fluoride, and to 
a control toothpaste with 1450 ppm fluoride:a three-day clinical study 
in new jersey, USA. J Clin Dent. 2009;20:123-30.
16. Olusile AO, Bamise CT, Oginni AO, Dosumu OO. Short-term cli-
nical evaluation of four desensitizing agents. J Contemp Dent Pract. 
2008;9:22-9.
17. Ozen T, Orhan K, Avsever H, Tunca YM, Ulker AE, Akyol M. Den-
tin hypersensitivity:a randomized clinical comparison of three different 
agents in a short-term treatment period. Oper Dent. 2009;34:392-8.
18. Bekes K, John MT, Schaller HG, Hirsch C. Oral health-related 
quality of life in patients seeking care for dentin hypersensitivity. J 
Oral Rehabil. 2009;36:45-51.
19. Canadian advisory board on dentin hypersensitivity. Consensus-
based recommendations for the diagnosis and management of dentin 
hypersensitivity. J Can Dent Assoc. 2003;69:221-6.
Acknowledgements
We would like to thank and express our gratitude to all the patients 
who participated in this trial selflessly.
Conflict of Interest
The authors declare no conflict of interest during the conduct of the 
trial.
